International Journal of Internal Medicine

International Journal of Internal Medicine is aimed to publish high-quality internationally competitive peer-reviewed original medical research, both laboratory and clinical, relating to the study and research of human disease. Papers will be considered from all areas of medical practice and science. It is an international journal dedicated to the latest advancement of internal medicine.

Lola Daminova

Editorial Board Member of International Journal of Internal Medicine

Professor, Tashkent State Medical University, Tashkent, Uzbekistan

Research Areas

Clinical Pharmacology; Internal Medicine; Rational Pharmacotherapy; Cardiovascular, Renal, Hepatic and Gastrointestinal Diseases

Education

2022Biocodex Learning in Healthcare Program: Antibiotic-induced Dysbiosis and the Role of ProbioticsBiocodex, Paris, France
2011Advanced Courses in TherapyTashkent, Uzbekistan
2006Advanced Postgraduate Training in Clinical PharmacologyAdvanced Postgraduate Training Center, Tashkent Medical Academy
2004Family Medicine SeminarFamily Practice Education International, Tulsa, Oklahoma, USA
2003Doctor of Medical Sciences (MD/Dr Med Sci); thesis: Clinical-pharmacological aspects of optimization of interferon therapy in acute liver diseasesFirst Tashkent State Medical Institute
1997PhD in Medicine; thesis: Pharmacological correction of functional and metabolic disorders in the lungs in chronic hepatitisFirst Tashkent State Medical Institute
1988Medical DoctorTashkent State Medical Institute

Experience

2014–presentProfessor, Department of Internal Medicine/Therapy, currently Tashkent State Medical University, Tashkent, Uzbekistan
2003–2014Professor, Department of Clinical Pharmacology, Tashkent Medical Academy
2000–2003Associate Professor (Docent), Department of Clinical Pharmacology, Tashkent Medical Academy
1997–2000Senior Scientist, Central Scientific Research Laboratory, First Tashkent State Medical Institute
1990–1997Scientist, Central Scientific Research Laboratory, First Tashkent State Medical Institute

Academic Achievement

Author/co-author of 4 monographs and 117 scientific publications.
Author of study guides and educational programs for medical students.
Experienced lecturer in clinical pharmacology, internal medicine and rational pharmacotherapy.
Opinion leader and practicing physician in contemporary healthcare and medical science.

Membership

European Atherosclerosis Society (EAS)
European Renal Association (ERA)
European Association for the Study of the Liver (EASL)

Publications: Journals

[1]  Daminova L.T., Muminova S.U., Nigmonov B.B., Adilova D.S. Laboratory Changes in Contrast-Induced Nephropathy in Patients with Type 2 Diabetes Mellitus. Diabetes Technology and Obesity Medicine. 2025;1(1):228–234. DOI: 10.1089/dtom.2025.0012. https://journals.sagepub.com/doi/10.1089/dtom.2025.0012
[2]  Daminova L.T. et al. Expert Consensus on Improving Clinical Approaches to Managing Liver Diseases in Patients with Comorbidities. 2025. https://family-medicine.com.ua/article/download/339469/327944/788838
[3]  Daminova L.T., Muminov Sh.K. et al. Impact of Percutaneous Coronary Intervention on Renal Function. Journal of Cardiorespiratory Research. https://cardiojournal.uz/index.php/journal/en/article/view/3
[4]  Daminova L.T., Adylova D.Sh. Effect of Hepatoprotectors on the Liver in Patients Who Have Had COVID-19. The Bulletin of Contemporary Clinical Medicine. 2022;15(5):22–26. DOI: 10.20969/VSKM.2022.15(5).22-26. https://vskmjournal.org/images/Files/Issues_Archive/2022/Issue_5/VSKM_2022_N_5_p22-26.pdf
[5]  Daminova L.T., Adylova D.Sh., Muminova S.U. Clinical and Laboratory Characteristics of Patients with Liver Damage in the Early Rehabilitation Period of COVID-19. The Bulletin of Contemporary Clinical Medicine. 2022;15(6):29–33. DOI: 10.20969/VSKM.2022.15(6).29-33. https://vskmjournal.org/ru/vypuski-zhurnala/52-2022-ru/313-tom-15-vypusk-6-2022.html
[6]  Daminova L.T., Adilova D.Sh., Muminova S.U. Structural and Functional Changes in the Liver in the Early Rehabilitation Period of COVID-19. Journal of Biomedicine and Practice. 2022;7(2):62–66. DOI: 10.5281/zenodo.6588996. https://www.sammu.uz/upload/d-file/files/62959d6d1c28f-62959d6d1c290-62959d6d1c291-62959d6d1c292.pdf
[7]  Daminova L.T., Kodirov Sh.S., Akbarova G.P. Effect of Anticoagulant Therapy on the State of the Gastroduodenal Zone in Patients with Ischemic Heart Disease. Journal of Biomedicine and Practice. 2021;6(3):86–92. DOI: 10.26739/2181-9300-2021-3-94. https://www.sammu.uz/upload/d-file/files/61705ea3cd7b3-61705ea3cd7b4-61705ea3cd7b5-61705ea3cd7b6.pdf

Publications: Conferences/Workshops/Symposiums

[1]  Daminova L.T., Muminov D.K., Muminova S.U. Structural and Functional Indicators of the Left Heart in the Aspect of Contrast-Induced Nephropathy. Nephrology Dialysis Transplantation. 2024;39(Suppl 1), Abstract #951. DOI: 10.1093/ndt/gfae069.1468. https://academic.oup.com/ndt/article/39/Supplement_1/gfae069-1468-951/7677839
[2]  Daminova L., Muminov Sh., Muminova S., Nigmonov B. The Role of Diabetes Mellitus in the Development of Contrast-Induced Nephropathy in Patients During X-ray Endovascular Procedures. Nephrology Dialysis Transplantation. 2024;39(Suppl 1), Abstract #731. DOI: 10.1093/ndt/gfae069.1342. https://academic.oup.com/ndt/article/39/Supplement_1/gfae069-1342-731/7677352
[3]  Daminova L. et al. Analysis of Risk Factors for the Development of Coronary Events in Patients with Chronic Kidney Disease Stage 5. Nephrology Dialysis Transplantation. 2024;39(Suppl 1), Abstract #1440. https://academic.oup.com/ndt/article/39/Supplement_1/gfae069-1384-1440/7678135
[4]  Daminova L., Muminova S. The Impact of Intradialytic Physical Activity on Inflammatory Markers in Patients with Diabetes Mellitus. Nephrology Dialysis Transplantation. 2025, Abstract #1393. https://academic.oup.com/ndt/article/doi/10.1093/ndt/gfaf116.1774/8295655